Sage Dental, a driver in the dental industry, has announced an exciting new partnership with Forward Science to introduce PerioStom®, an advanced, non-drug periodontal therapy aimed at improving patient recovery and outcomes following scaling and root planing (SRP) procedures.
https://mma.prnewswire.com/media/2749857/Sage_Dental_Logo.jpg
PerioStom®, an FDA-cleared treatment, utilizes cutting-edge chitosan microspheres to protect and promote healing of the oral mucosa after iatrogenic procedures like SRP. This innovative therapy has been developed to optimize the recovery process and deliver measurable improvements in clinical outcomes.
The collaboration between Sage Dental and Forward Science, which began in 2024, focused on assessing the clinical impact ofPerioStom®in real-world patient settings. Patients undergoing SRP were treated with chitosan-based powder, and their progress was monitored through a 30-day follow-up period. Key metrics evaluated included pocket depth, bleeding on probing, inflammation levels, and the Oral Hygiene Index. Results demonstrated significant improvements in these critical areas, signaling the therapy's effectiveness in enhancing patient recovery.
“At Sage Dental, we have always been committed to advancing patient care through innovation,” said Misty Mattingly, SVP and Chief of Dental Hygiene Operations at Sage Dental. “Our Clinical Leadership team is passionate about incorporating new solutions that lead to better outcomes. The idea for PerioStom® originated at Forward Science's Moving Science Forward Summit in 2018 that I attended. With Sage's love for innovation, we were happy to partner on a product that delivers results, is not an antibiotic, and can be used at the earliest sign of disease. At Sage, we are focused on saving teeth, and PerioStom® is another option to support our mission.”
Robert J. Whitman, CEO of Forward Science, shared, “We are thrilled to collaborate with Sage Dental on launching such a transformative product. The partnership is a natural fit, given Sage Dental's leadership in the field and their commitment to pioneering advancements in patient care.”
PerioStom®is now available to dental practices nationwide, providing a non-invasive, non-drug solution that enhances the efficacy of traditional SRP treatments, ensuring that patients receive the highest level of care and faster recovery times.
About Sage DentalSage Dental Group operates as a trusted leader in dental care, serving communities throughout the Southeastern U.S. with a commitment to top-tier clinical expertise, patient comfort, and innovative treatment solutions. With over 140 practices, Sage Dental has provided care to over one million patients through a broad network offering general, specialty, and cosmetic dental services, including restorative,prosthodontic, endodontic, oral surgery, periodontics, pediatric, and orthodontic treatment. Sage Dental participates in most dental plans and provides various payment and financing options to ensure accessible care for all patients.
Dental practices interested in learning more about joining Sage Dental can contact Chief Development Officer Jim Mizouni at jmizouni@mysagedental.com.For media inquiries, please contact marketing@mysagedental.com.
For a complete list of services and locations, please visit www.mysagedental.com or follow @MySageDental on Facebook, Instagram, and Twitter.
https://c212.net/c/img/favicon.png?sn=FL50772&sd=2025-08-19
View original content to download multimedia:https://www.prnewswire.com/news-releases/sage-dental-partners-with-forward-science-to-launch-revolutionary-non-drug-periodontal-therapy-302531304.html
SOURCE Sage Dental
https://rt.newswire.ca/rt.gif?NewsItemId=FL50772&Transmission_Id=202508190800PR_NEWS_USPR_____FL50772&DateId=20250819